STOCK TITAN

Guardian Pharmacy (GRDN) finance SVP details stock, options and RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. executive William Franklin Mudd, Senior Vice President of Finance, filed an initial statement of ownership as a reporting insider. He directly holds 98,465 shares of Class A common stock and 38,282 shares of Class B common stock that convert into Class A on September 27, 2026 on a one-for-one basis.

He also holds stock options covering 25,000 shares of Class A common stock with a $34.59 exercise price, vesting and becoming exercisable in full on February 11, 2029. In addition, his position includes 7,594 and 4,476 restricted stock units that vest on February 14, 2028 and March 1, 2029, respectively, each settling one-for-one in Class A shares.

Positive

  • None.

Negative

  • None.
Insider Mudd William Franklin
Role Senior Vice President, Finance
Type Security Shares Price Value
holding Class B Common Stock -- -- --
holding Stock Option (right to buy) -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class B Common Stock — 38,282 shares (Direct); Stock Option (right to buy) — 25,000 shares (Direct); Class A Common Stock — 98,465 shares (Direct)
Footnotes (1)
  1. Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full on February 14, 2028 and March 1, 2029, respectively, are settled on a one-for-one basis in shares of Guardian Pharmacy Services, Inc.'s (the "Issuer") Class A common stock. Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of the Issuer's Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026. This option shall vest and become exercisable in full on February 11, 2029.
Class A common stock held 98,465 shares Direct holdings as reported on Form 3
Class B common stock held 38,282 shares Automatically convert to Class A on September 27, 2026
Stock option underlying shares 25,000 shares Class A common stock under option vesting February 11, 2029
Stock option exercise price $34.59 per share Exercise price for 25,000-share option position
RSUs vesting February 14, 2028 7,594 units Settle one-for-one into Class A common stock
RSUs vesting March 1, 2029 4,476 units Settle one-for-one into Class A common stock
Class B conversion date September 27, 2026 Automatic one-for-one conversion into Class A shares
Option vesting date February 11, 2029 Date option becomes fully exercisable
restricted stock units financial
"Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class B common stock financial
"the Reporting Person's shares of the Issuer's Class B common stock automatically convert..."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
automatically convert financial
"Class B common stock automatically convert into shares of the Issuer's Class A common stock..."
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) with an exercise price of 34.5900..."
exercise price financial
"conversion_or_exercise_price: 34.5900 for the stock option position..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"This option shall vest and become exercisable in full on February 11, 2029."
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Mudd William Franklin

(Last)(First)(Middle)
300 GALLERIA PARKWAY SE, SUITE 800

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026
3. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Senior Vice President, Finance
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock98,465(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock (2) (2)Class A Common Stock38,282(2)D
Stock Option (right to buy) (3)02/11/2036Class A Common Stock25,000$34.59D
Explanation of Responses:
1. Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full on February 14, 2028 and March 1, 2029, respectively, are settled on a one-for-one basis in shares of Guardian Pharmacy Services, Inc.'s (the "Issuer") Class A common stock.
2. Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of the Issuer's Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.
3. This option shall vest and become exercisable in full on February 11, 2029.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Douglas Towns, Attorney-in-Fact04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing by GRDN executive William Franklin Mudd show?

The Form 3 shows that Senior Vice President of Finance William Franklin Mudd is a reporting insider holding Class A and Class B common stock, stock options, and restricted stock units in Guardian Pharmacy Services, Inc., establishing his initial beneficial ownership position.

How many GRDN Class A common shares does William Franklin Mudd hold?

William Franklin Mudd directly holds 98,465 shares of Guardian Pharmacy Services, Inc. Class A common stock. This figure represents his reported Class A share ownership as of the Form 3 filing date, separate from any Class B shares, options, or restricted stock units.

What Class B common stock holdings of GRDN does the Form 3 disclose?

The filing discloses that William Franklin Mudd holds 38,282 shares of Class B common stock. According to the company’s charter, these Class B shares automatically convert into Class A common stock on a one-for-one basis on September 27, 2026, increasing his Class A exposure.

What stock options in Guardian Pharmacy Services, Inc. does William Franklin Mudd own?

He holds a stock option covering 25,000 shares of Class A common stock with a $34.59 exercise price. The option is scheduled to vest and become fully exercisable on February 11, 2029, giving him potential future purchase rights at that price.

What restricted stock units (RSUs) in GRDN are reported for William Franklin Mudd?

The Form 3 notes 7,594 and 4,476 restricted stock units that settle in Class A shares. These RSUs vest in full on February 14, 2028 and March 1, 2029, respectively, each unit converting into one share of Guardian Pharmacy Services, Inc. Class A common stock.

When do William Franklin Mudd’s GRDN equity awards and conversions occur?

Key future dates include September 27, 2026 for automatic conversion of Class B to Class A shares, February 14, 2028 and March 1, 2029 for RSU vesting, and February 11, 2029 when his 25,000-share option becomes fully exercisable.